IL-27 inhibits the development of regulatory T cells via STAT3

International Immunology

Volumn 20, Issue 2, 2008, Pages 223-234

  Huber, Magdalena ^a   Steinwald, Vera ^a   Guralnik, Anna ^a   Brüstle, Anne ^a   Kleemann, Peter ^a   Rosenplänter, Christine ^a   Decker, Thomas ^b   Lohoff, Michael ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

IL 27; STAT1; STAT3; TGF ; Treg

Indexed keywords

CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 27; SMALL INTERFERING RNA; STAT1 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HOMEOSTASIS; IMMUNE SYSTEM; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; TH1 CELL;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; FORKHEAD TRANSCRIPTION FACTORS; INTERLEUKIN-2; INTERLEUKINS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; RNA INTERFERENCE; RNA, SMALL INTERFERING; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA1;

EID: 39049152572     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxm139     Document Type: Article

References (43)

1. Pflanz, S., Timans, J. C., Cheung, J. et al. 2002. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16:779.
2. Wirtz, S., Becker, C., Fantini, M. C. et al. 2005. EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kappa B activation. J. Immunol. 174:2814.
3. Schnurr, M., Toy, T., Shin, A., Wagner, M., Cebon, J. and Maraskovsky, E. 2005. Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: A novel role for the cAMP pathway. Blood 105:1582.
4. Liu, J., Guan, X. and Ma, X., 2007. Regulation of IL-27 p28 gene expression in macrophages through MyD88- and- interferon-gamma-mediated pathways. J. Exp. Med. 204:141.
5. Pflanz, S., Hibbart, L., Mattson, J. et al. 2004. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27 J. Immunol. 172:2225.
6. Wirtz, S., Tubbe., I., Galle, P. R. et al. 2006. Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. J. Exp. Med. 203:1875.
7. Villarino, A. V., Larkin, J. III, Saris, C. J. et al. 2005. Positive and negative regulation of the IL-27 receptor during lymphoid cell activation. J. Immunol. 174:7684.
8. Hibbert, L., Pflanz, S., de Waal, M. R. and Kastelein, R. A. 2003. IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells. J. Interferon Cytokine Res. 23:513.
9. Lucas, S., Ghilardi, N., Li, J. and de Sauvage, F. J. 2003. IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms. Proc. Natl Acad. Sci. USA 100:15047.
10. Kamiya, S., Owaki, T., Morishima, N., Fukai, F., Mizuguchi, J. and Yoshimoto, T. 2004: An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells. J. Immunol. 173:3871.
11. Owaki, T., Asakawa, M., Fukai, F., Mizuguchi, J. and Yoshimoto, T. 2006. IL-27 induces Th1 differentiation via p38 MAPK/T-bet- and intercellular adhesion molecule-1/LFA-1/ERK1/2-dependerit pathways. J. Immunol. 177:7579.
12. Takeda, A., Hamano, S., Yamanaka, A. et al. 2003. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J. Immunol. 170:4886.
13. Yoshimoto, T., Yoshimoto, T., Yasuda, K., Mizuguchi, J. and Nakanishi, K. 2007. IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells: A novel therapeutic way for Th2-mediated allergic inflammation. J. Immunol. 179:4415.
14. Batten, M., Li, J., Yi, S. et al. 2006. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7:929.
15. Stumhofer, J. S., Laurence, A., Wilson, E. H. et al. 2006. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7:937.
16. Villarino, A. V., Stumhofer, J. S., Saris, C. J., Kastelein, R. A., de Sauvage, F. J. and Hunter, C. A. 2006. IL-27 limits IL-2 production during Th1 differentiation. J. Immunol. 176:237.
17. Owaki, T., Asakawa, M., Kamiya, S. et al. 2006. IL-27 suppresses CD28-mediated [correction of medicated] IL-2 production through suppressor of cytokine signaling 3. J. Immunol. 176:2773.
18. Yoshimura, T., Takeda, A., Hamano, S. et al. 2006. Two-sided roles of IL-27: Induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J. Immunol. 177:5377.
19. Shevach, E. M., DiPaolo, R. A., Andersson, J., Zhao, D. M., Stephens, G. L. and Thornton, A. M. 2006. The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells. Immunol. Rev. 212:60.
20. Sakaguchi, S. 2004. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22:531.
21. Li, M. O., Sanjabi, S. and Flavell, R. A. 2006. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25:455.
22. Marie, J. C., Liggitt, D. and Rudensky, A. Y. 2006. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity 25:441.
23. Hori, S., Nomura, T. and Sakaguchi, S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057.
24. Gavin, M. A., Rasmussen, J. P., Fontenot, J. D. et al. 2007. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445:771.
25. Khattri, R., Cox, T., Yasayko, S. A. and Ramsdell, F. 2003. An assential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4:337.
26. Wildin, R. S., Ramsdell, F., Peake, J. et al. 2001. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27:18.
27. Bennett, C. L., Christie, J., Ramsdell, F. et al. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27:20.
28. Bettelli, E., Carrier, Y., Gao, W. et al. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235.
29. Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. and Stockinger, B. 2006. TGFbeta in the context of an inflammatory cytokine milieu supports cle novo differentiation of IL-17-producing T cells. Immunity 24:179.
30. Yang, X. O., Panopoulos, A. D., Nurieva, R. et al. 2007. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 282:9358.
31. Yao, Z., Kanno, Y., Kerenyi, M. et al. 2007. Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood109:4368.
32. Zhou, L., Ivanov, I. I., Spolski, R. et al. 2007. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8:967.
33. Neufert, C., Becker, C., Wirtz, S. et al. 2007. IL-27 controls the development of inducible regulatory T cells ard Th17 cells via differential effects on STAT1. Eur. J. Immunol.37:1809.
34. Korn, T., Bettelli, E., Gao, W. et al. 2001. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448:484.
35. Kastelein, R. A., Hunter, C. A. and Cua, D. J. 2007. Discovery and biology of JL-23 and IL-27: Related but functionally distinct regulators of inflammation. Annu. Rev Immunol. 25:221.
36. Lohoff, M., Mittrucker, H. W., Precht, S. et al. 2002. Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4. Proc. Natl Acad. Sci. USA 99:11808.
37. Liu, X., Shi, Q. and Sigmund, C. D. 2006. Interleukin-1 beta attenuates renin gene expression via a mitogen-activated protein kinase kinase-extracellular signal-regulated kinase and signal transducer and activator of transcription 3-dependent mechanism in As4.1 cells. Endocrinology 147.6011.
38. Sumita, N., Bito, T., Nakajima, K. and Nishigori, C. 2006. Stat3 activation is required for cell proliferation and tumorigenesis but not for cell viability in cutaneous squamous cell carcinoma cell lines. Exp. Dermatol. 15:291.
39. Fontenot, J. D., Gavin, M. A. and Rudensky, A. Y. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 4:330.
40. Lin, J. T., Martin, S. L., Xia, L. and Gorham, J. D. 2005. TGF-beta 1 uses distinct mechanisms to inhibit IFN-gamma expression in CD4+ T-cells at priming and at recall: Differential involvement of Stat4 and T-bet. J. Immunol. 174:5950.
41. Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T. and Akira, S. 1998. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: Generation and characterization of T cell-specific Stat3-deficient mice. J. Immunol. 161:4652.
42. Schmidt, C., Gibse, T., Ludwig, B, et al. 2005. Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease elevated interleukin-23p19 and interleukin-27p28 in Crohns disease but not in ulcerative colitis. Inflamm. Bowel Dis., 11:16.
43. Honda, K., Nakamura, K., Matsui, N. et al. 2005. T helper 1-inducing property of IL-27/WSX-1 signaling is required for the induction of experimental colitis. Inflamm. Bowel Dis. 11:1044.